Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCQB - Delayed Quote USD

Unidoc Health Corp. (UDOCF)

Compare
0.2300
0.0000
(0.00%)
At close: April 10 at 4:00:00 PM EDT
Loading Chart for UDOCF
  • Previous Close 0.0000
  • Open 0.2580
  • Bid 0.2134 x 301500
  • Ask 0.2260 x --
  • Day's Range 0.2450 - 0.2580
  • 52 Week Range 0.1750 - 0.7200
  • Volume 7,000
  • Avg. Volume 26,558
  • Market Cap (intraday) 17.548M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0600
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Unidoc Health Corp. operates as a healthcare services company in Canada. It offers Virtual eHealth Clinics, which connects patients in urban, rural, and remote locations with medical care. The company's solutions include kiosks and self-test centers, remote lab testers, self-check in and testing with AI triage powered assistant, automatic pharma dispensing machines, and access to doctor and hospital networks. The company was formerly known as Unicheck Holdings Corp. and changed its name to UniDoc Health Corp. in April 2021. The company was incorporated in 2021 and is headquartered in Woodbridge, Canada.

www.unidoctor.com

--

Full Time Employees

--

Fiscal Year Ends

Recent News: UDOCF

View More

Performance Overview: UDOCF

Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

UDOCF
30.30%
S&P/TSX Composite index (^GSPTSE)
6.52%

1-Year Return

UDOCF
45.24%
S&P/TSX Composite index (^GSPTSE)
3.67%

3-Year Return

UDOCF
45.24%
S&P/TSX Composite index (^GSPTSE)
5.21%

5-Year Return

UDOCF
45.24%
S&P/TSX Composite index (^GSPTSE)
62.46%

Compare To: UDOCF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: UDOCF

View More

Valuation Measures

Annual
As of 4/9/2025
  • Market Cap

    17.13M

  • Enterprise Value

    15.41M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    15.64

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    -0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: UDOCF

View More

Company Insights: UDOCF

Research Reports: UDOCF

View More

People Also Watch